Prolonged treatment of Menetrier's disease with an oral anticholinergic drug

Keyphrases

• Prolonged Treatment 100%
• Ménétrier's Disease 100%
• Oral Anticholinergic 100%
• Serum Proteins 66%
• Albumin 33%
• Long-term Treatment 33%
• Protein Components 33%
• Drug Therapy 33%
• Plasma Proteins 33%
• Treatment Duration 33%
• Gastrectomy 33%
• Serial Measurements 33%
• Total Serum Protein 33%
• Serum Protein Concentrations 33%
• Protein Shedding 33%
• Antisecretory Drugs 33%
• Protein-losing Gastropathy 33%
• Propantheline Bromide 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Cholinergic Receptor Blocking Agent 100%
• Plasma Protein 100%
• Menetrier Disease 100%
• Pharmacotherapy 25%
• Albumin 25%
• Protein Losing Gastroenteropathy 25%
• Propantheline Bromide 25%
• Diseases 25%